Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients

Authors
Category Primary study
ConferenceAllergy: European Journal of Allergy and Clinical Immunology
Year 2016
This article has no abstract
Epistemonikos ID: 191f80c1c60455fc3ce8872da39ceaf81acb2d45
First added on: Apr 29, 2026